Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
156.4 USD | +0.84% | -4.47% | -13.29% |
Financials (USD)
Sales 2024 * | 3.08B | Sales 2025 * | 3.93B | Capitalization | 16.33B |
---|---|---|---|---|---|
Net income 2024 * | -874M | Net income 2025 * | -350M | EV / Sales 2024 * | 4.79 x |
Net cash position 2024 * | 1.58B | Net cash position 2025 * | 1.18B | EV / Sales 2025 * | 3.86 x |
P/E ratio 2024 * |
-18.3
x | P/E ratio 2025 * |
-48.9
x | Employees | 10,600 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.21% |
Latest transcript on BeiGene, Ltd.
1 day | +0.84% | ||
1 week | -7.80% | ||
Current month | -5.59% | ||
1 month | -12.97% | ||
3 months | -12.60% | ||
6 months | -18.62% | ||
Current year | -13.29% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.48% | 4 M€ | -27.92% | ||
1.49% | 0 M€ | 0.00% | - | |
1.39% | 9 M€ | -4.31% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 156.4 | +0.84% | 104,129 |
24-03-27 | 155.1 | +0.83% | 76,134 |
24-03-26 | 153.8 | -0.07% | 104,417 |
24-03-25 | 153.9 | +1.25% | 122,678 |
24-03-22 | 152 | -7.14% | 445,487 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.29% | 16.19B | |
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
+4.68% | 13.72B | |
+34.25% | 12.22B | |
-6.78% | 10.36B |